Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Katsunori Katagiri is active.

Publication


Featured researches published by Katsunori Katagiri.


Auris Nasus Larynx | 2011

An analysis of clinical risk factors of deep neck infection.

Jun Hasegawa; Hiroshi Hidaka; Masaru Tateda; Takayuki Kudo; Shun Sagai; Makiko Miyazaki; Katsunori Katagiri; Ayako Nakanome; Eiichi Ishida; Daiki Ozawa; Toshimitsu Kobayashi

OBJECTIVES To clarify the clinical risk factors that aggravate deep neck infection. PATIENTS AND METHODS Sixty-five patients with deep neck infection (abscess or cellulitis), 42 males and 23 females, who were treated at the ear, nose, and throat department in Iwaki Kyoritsu General Hospital in the past 10 years, were retrospectively reviewed. Cases of inflammation of the upper airway including the oral cavity, laryngopharynx, palate tonsil and salivary gland, and cases of lymphadenitis were investigated. These patients were divided into five localized types and one wide range type according to the abscess locations as follows: oral cavity floor type, upper deep cervical type, submandibular type, submental type, retropharyngeal type, and wide range type. RESULTS Seventeen of the 65 patients had diabetes, and significantly more diabetics had the wide range type than the localized type (P<0.05, Fishers test). Diabetes complication was more often seen in the upper deep cervical type among patients aged 61 years or older, and in the wide range type among males aged 41 years or older and elderly women aged 61 years or older. No patients with odontogenic infection or sialolithiasis had associated diabetes mellitus. Two cases developed mediastinitis, and one was caused by retrotonsillar abscess and needed thoracic drainage. More than half of the wide range type cases and more than a quarter of each of the localized type cases except the upper deep cervical type also had laryngeal edema, and eight of them needed emergency tracheotomy. Thirteen of the 40 cases had bacteria belonging to the Streptococcus milleri group (SMG), and all were detected in patients who underwent surgical drainage. Four of the 13 cases where SMG was detected showed drug resistance to some sorts of antibiotics. CONCLUSION Oral disorders can develop deep neck infection independently of the presence of diabetes mellitus, compared with other causes. The presence of diabetes mellitus is associated with deep neck infection, aggravating parotitis and wide spread of inflammation. Retrotonsillar abscess often spreads to the retropharyngeal and parapharyngeal spaces, causing mediastinitis, so caution is necessary. Infection due to SMG tends to form abscess independently of diabetes mellitus. Since more than half of the wide range type and more than a quarter of each of the localized types except the upper deep cervical type were associated with laryngeal edema, airway management should be considered.


Japanese Journal of Clinical Oncology | 2014

Effect of HMB/Arg/Gln on the Prevention of Radiation Dermatitis in Head and Neck Cancer Patients Treated with Concurrent Chemoradiotherapy

Takayuki Imai; Kazuto Matsuura; Yukinori Asada; Shun Sagai; Katsunori Katagiri; Eiichi Ishida; Daisuke Saito; Rei Sadayasu; Hitoshi Wada; Shigeru Saijo

OBJECTIVE This prospective randomized Phase II study was designed to evaluate the preventive effect of an oral nutrition supplement composed of beta-hydroxy-beta-methylbutyrate, arginine and glutamine (beta-hydroxy-beta-methylbutyrate/arginine/glutamine) on radiation dermatitis in head and neck cancer patients. METHODS Forty patients with histologically proven head and neck cancer, treated with concurrent chemoradiotherapy involving cisplatin were recruited. They were randomly assigned to the beta-hydroxy-beta-methylbutyrate/arginine/glutamine supplement treatment group (Group A) or the control group that received no supplement (Group B). The primary endpoint of this study was the percentage of patients developing ≥Grade 3 dermatitis. The secondary endpoints were the percentage of patients developing ≥Grade 2 dermatitis, and the duration of each grade of dermatitis relative to the observation period. RESULTS The incidence of ≥Grade 3 dermatitis did not differ between the two groups. However, as secondary endpoints of this study, the incidence of ≥Grade 2 dermatitis was lower in Group A than B (62.6 vs. 94.4%; P < 0.05), and the duration of ≥Grade 1 dermatitis was shorter in Group A than B (44.8 vs. 56.7%; P < 0.01), as was the duration of ≥Grade 2 dermatitis (16.5 vs. 26.5%; P < 0.05). CONCLUSIONS Our study indicated that beta-hydroxy-beta-methylbutyrate/arginine/glutamine supplementation was potentially effective in the prevention of radiation dermatitis in head and neck cancer patients.


Acta Oto-laryngologica | 2016

Carcinoma ex pleomorphic adenoma of the parotid gland: a multi-institutional retrospective analysis in the Northern Japan Head and Neck Cancer Society

Masahiro Suzuki; Takashi Matsuzuka; Satoshi Saijo; Miki Takahara; Yasuaki Harabuchi; Tsuyoshi Okuni; Tetsuo Himi; Tomohiko Kakizaki; Satoshi Fukuda; Kazuyuki Yamada; Tatsumi Nagahashi; Takahisa Abe; Hideichi Shinkawa; Katsunori Katagiri; Hiroaki Sato; Naoko Fukui; Kazuo Ishikawa; Takahiro Suzuki; Toshimitsu Kobayashi; Daisuke Saito; Shigeru Saijo; Masaru Tateda; Sho Hashimoto; Akihiro Ishida; Seiji Kakehata; Osamu Suzuki; Yuko Hashimoto; Koichi Omori

Abstract Conclusion: The 3-year progression-free survival rate of non-invasive salivary duct carcinoma (SDC) or adenocarcinoma not otherwise specified (NOS) was significantly better than that of invasive SDC or adenocarcinoma NOS in Carcinoma ex pleomorphic adenoma (CXPA). The presence of invasion is an important prognostic factor for SDC and adenocarcinoma NOS in CXPA. Objectives: CXPA is a rare parotid gland malignant tumor for which therapy is not yet standardized. The purpose of this study was to review the characteristics of CXPA patients and to analyze their outcomes in the Northern Japan Head and Neck Cancer Society. Method: The medical records of 33 patients who had been provided initial treatment in 12 institutes of northern Japan from 2002–2011 were reviewed as a multi-institutional retrospective study. Results: The 3-year overall and progression-free survival rate of all patients was 79.9% and 76.8%, respectively. Both the 3-year overall and progression-free survival rates were 87.5% for patients with non-invasive SDC or adenocarcinoma NOS. The 3-year overall and progression-free survival rates for patients with invasive SDC or adenocarcinoma NOS were 60.4% and 30.5%, respectively. The progression-free survival rates for patients with invasive SDC or adenocarcinoma NOS was significantly poor (p < 0.05).


Tohoku Journal of Experimental Medicine | 2018

Treatment with Lactobacillus Retards the Tumor Growth of Head and Neck Squamous Cell Carcinoma Cells Inoculated in Mice

Jun Miyaguchi; Kiyoto Shiga; Kazumi Ogawa; Fumiko Suzuki; Katsunori Katagiri; Daisuke Saito; Aya Ikeda; Akira Horii; Mika Watanabe; Shizunobu Igimi

Bacteria have been used for more than a century to treat solid tumors. Because solid tumors generate an anaerobic environment, we evaluated the anti-tumor effect of the obligate anaerobe strain KK378, derived from Lactobacillus casei (L. casei), using mice bearing head and neck cancer. Wild-type L. casei is a nonpathogenic bacterium that is commonly used in foods. Moreover, patients with head and neck squamous cell carcinoma often have multiple cancers and cervical lymph node metastasis that can be directly sensed beneath the skin. To establish the animal model bearing head and neck cancer, we inoculated each of human squamous cell carcinoma cell lines, SAS, HSQ89, and HSC2, on the back skin of BALB/cSlc-nu/nu mice. After tumor formation, L. casei KK378 was administered directly into the tumor, and tumor size and serum cytokine levels were analyzed. Mice injected with 108 cfu of L. casei KK378 showed reduction in tumor growth compared with PBS control; especially, the SAS tumor was significantly reduced (p = 0.008). Administered L. casei KK378 was detected in tumor tissues but not in normal tissues (liver, kidney, and lung) of SAS tumor-bearing mice, which was associated with increased blood cytokines (TNF-α, IFN-γ, IL-5, IL-10, and IL-12). Among these cytokines, the serum levels of IFN-γ and TNF-α were significantly increased (p < 0.05). In conclusion, L. casei KK378 infection may suppress tumor growth by inducing the host immune response. Direct injection of Lactobacillus into the tumor could be a potential strategy to treat head and neck squamous cell carcinoma.


Skull Base Surgery | 2018

Long-Term Outcomes of Patients with Squamous Cell Carcinoma of the Temporal Bone after Concomitant Chemoradiotherapy

Kiyoto Shiga; Katsunori Katagiri; Daisuke Saitoh; Takenori Ogawa; Kenjiro Higashi; Hisanori Ariga

Objectives This article aims to clarify the long‐term outcomes of patients with squamous cell carcinoma of the temporal bone who underwent concomitant chemoradiotherapy (CCRT). Design and Setting The study design was a retrospective chart review. Patients and Methods From December 2001 to June 2014, 23 patients with cancer of the temporal bone who were treated by CCRT at the Tohoku University Hospital and the Iwate Medical University Hospital were enrolled in this study. For advanced cancer of the temporal bone, a modified docetaxel, cisplatin, and 5‐fluorouracil (TPF) regimen was used for CCRT. The long‐term outcomes, including prognoses and late complications, were analyzed after CCRT of patients with cancers of the temporal bone. Results The main long‐term complications were stenosis of the external auditory canal and conductive hearing loss. No harmful late complications were observed in these patients. Disease‐specific survival rates were 84.9% for all patients, 100% for patients of stage I, II, and III (n = 10), and 75.5% for patients of stage IV (n = 13) at 5 years. Conclusions Our study showed that CCRT is an effective treatment choice for squamous cell carcinoma of the temporal bone. Furthermore, CCRT using the TPF regimen is a safe and effective initial treatment for patients with advanced cancers of the temporal bone.


Oncology Letters | 2018

Association between contrast-enhanced ultrasonography and histopathological findings of the metastatic lymph nodes of patients with head and neck cancer: A preliminary study

Shin‑Ichi Oikawa; Kiyoto Shiga; Daisuke Saito; Katsunori Katagiri; Aya Ikeda; Kodai Tuchida; Jun Miyaguchi; Kazuyuki Ishida; Tamotsu Sugai

The present study aimed to investigate the usefulness of contrast-enhanced ultrasonography (CEUS) and a newly developed analysis software for the detection of microcapillary network distribution in lymph nodes of patients with head and neck cancer (HNC) by comparing the CEUS and histopathological findings. Patients that were diagnosed with HNC between February and September 2016 were enrolled. A total of five patients underwent resection of the primary tumor and neck dissection as their initial treatment. The cervical lymph nodes of these patients were analyzed by CEUS intraoperatively, and their surgical specimens were examined histopathologically. The patients were diagnosed using a combination of physical examination, computed tomography, magnetic resonance imaging and fluorodeoxyglucose-positron emission tomography. For CEUS examination, the microbubble contrast agent Sonazoid™ was injected into a peripheral vein. Video images of the metastatic lymph nodes were captured, and these were subjected to analysis by a newly developed image-analysis software. It was possible to perform intraoperative CEUS of metastatic lymph nodes and obtain accurate matched sections for histopathological examination. Hematoxylin and eosin and cluster of differentiation (CD)34 staining revealed that the software was able to accurately detect capillary vessels in metastatic lymph nodes. However, a number of perfusion deficits were observed in these lymph nodes. In conclusion, by using CEUS with the analysis software, the density and distribution of blood vessels in the metastatic lymph nodes of patients with HNC was revealed. Although the present study was limited and preliminary, it was concluded that this method may be useful to evaluate and to map the capillary vessels in the metastatic lymph nodes of patients with HNC.


Oncology Letters | 2017

Multi-institutional survey of carotid body tumors in Japan

Aya Ikeda; Kiyoto Shiga; Katsunori Katagiri; Daisuke Saito; Jun Miyaguchi; Shin‑Ichi Oikawa; Kodai Tsuchida; Takahiro Asakage; Hiroyuki Ozawa; Ken-ichi Nibu; Naoki Ohtsuki; Yasushi Fujimoto; Ken‑Ichi Kaneko

There has been no attempt to clarify the status of patients with carotid body tumor (CBT) in Japan. This multi-institutional survey analyzed patients with CBT throughout Japan by gathering information on these patients from institutions that performed head and neck surgeries. Information from a total of 150 patients from 25 institutions from the past 20 years was employed in the present survey. There were 87 females and 63 males, and their mean age was 48.0 years old. The most common chief complaint was a neck mass and the mean suffering period was 46.1 months. Eighteen patients had a family history of paragangliomas and fifteen patients had bilateral CBTs. Among the 94 patients who underwent surgery to remove a CBT, 23 patients had tumors classified as Shamblin type I, 59 had type II and 12 had type III. The most frequent feeding artery of these CBTs was the ascending pharyngeal artery. Preoperative embolization of these arteries was effective in reducing blood loss; however, the operation time in Shamblin type I and II tumors was not improved. Thus these results revealed the status of patients with CBT and their treatment throughout Japan.


Archive | 2012

Management of Early-Stage Tongue Cancer

Kiyoto Shiga; Katsunori Katagiri; Ayako Nakanome; Takenori Ogawa; Toshimitsu Kobayashi

In general, tongue cancer is usually treated surgically and additional therapy is carried out if patients have advanced cancers. Although surgical treatment is performed at the early stage of tongue cancer, still some problems emerge, such as late cervical lymph node metastasis and elective neck dissection. We previously recommended elective neck dissection for patients with T2 tongue cancers (Tateda et al., 2000). However, the range of tumor sizes that would require elective neck dissection remains to be determined.


Tohoku Journal of Experimental Medicine | 2011

Distinct features of second primary malignancies in head and neck cancer patients in Japan.

Kiyoto Shiga; Masaru Tateda; Katsunori Katagiri; Ayako Nakanome; Takenori Ogawa; Yukinori Asada; Kengo Kato; Toshimitsu Kobayashi


Oncology Letters | 2012

Differences between oral cancer and cancers of the pharynx and larynx on a molecular level

Kiyoto Shiga; Takenori Ogawa; Katsunori Katagiri; Fumiaki Yoshida; Masaru Tateda; Kazuto Matsuura; Toshimitsu Kobayashi

Collaboration


Dive into the Katsunori Katagiri's collaboration.

Top Co-Authors

Avatar

Kiyoto Shiga

Iwate Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Aya Ikeda

Iwate Medical University

View shared research outputs
Top Co-Authors

Avatar

Daisuke Saito

Iwate Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge